-
are readable by sequencing. As a member of the group you become a part of the SciLifeLab community and the unit for microbiology-bacteriology at the Karolinska Institute. Your mission Antibodies
-
at the Science for Life Laboratory (SciLifeLab, http://www.scilifelab.se/ ) in the Karolinska Institute campus. SciLifeLab is equiped with state-of-the-art instrumentation and core facilities, and is home to one
-
at the Science for Life Laboratory (SciLifeLab, http://www.scilifelab.se/ ) in the Karolinska Institute campus. SciLifeLab is equiped with state-of-the-art instrumentation and core facilities, and is home to one
-
Do you want to contribute to top quality medical research? The Nyberg lab is a newly formed research group at the Karolinska Institute. The overall aim of the Nyberg lab is to develop and use
-
malaria research at Karolinska Institute. Our unit is strongly focused on the chemotherapy of antimalarials, in particular the management of Plasmodium falciparum malaria. Parasite drug resistance is the
-
at the Science for Life Laboratory in the Karolinska Institute campus. SciLifeLab is equiped with state-of-the-art instrumentation and core facilities, and is home to one of the largest sequencing cluster in
-
is placed within the multinational EUbOPEN consortium and guarantees insights in projects too large for one lab. Division At the Center of Molecular Medicine (CMM), we are situated between Karolinska
-
Do you want to contribute to top quality medical research? We are looking for a Research Specialist for a permanent position, 30 %. Description of the subject area Our translational research program is focused on designing therapies for the treatment of immunological diseases. The Research...
-
of Experimental Medical Science. The project’s co-investigator is Andrea Fossati, Karolinska Institute, Stockholm. Specifically, the project will be on finding the prophages of Escherichia coli genomes and
-
infection.” In the lab of Gemma Atkinson in Lund University, Department of Experimental Medical Science. The project’s co-investigator is Andrea Fossati, Karolinska Institute, Stockholm. Specifically